John Fowler
2019
In 2019, John Fowler earned a total compensation of $3.5M as Chief Executive Officer at Kezar Life Sciences, a 96% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $183,750 |
|---|---|
| Option Awards | $2,811,480 |
| Salary | $525,000 |
| Other | $11,794 |
| Total | $3,532,024 |
Fowler received $2.8M in option awards, accounting for 80% of the total pay in 2019.
Fowler also received $183.8K in non-equity incentive plan, $525K in salary and $11.8K in other compensation.
Rankings
In 2019, John Fowler's compensation ranked 3,438th out of 13,971 executives tracked by ExecPay. In other words, Fowler earned more than 75.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,438 out of 13,971 | 75th |
Division Manufacturing | 1,247 out of 5,701 | 78th |
Major group Chemicals And Allied Products | 429 out of 2,200 | 81st |
Industry group Drugs | 357 out of 1,886 | 81st |
Industry Pharmaceutical Preparations | 269 out of 1,398 | 81st |
Source: SEC filing on April 29, 2020.
Fowler's colleagues
We found three more compensation records of executives who worked with John Fowler at Kezar Life Sciences in 2019.